• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Trending
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Germany

layoffs cuts workforce reduction chairs boxes fired
Biotech

BioNTech cuts 90 more US jobs as part of pipeline realignment

The layoffs come as BioNTech redefines its pipeline priorities to focus on therapeutic approaches with pan-tumor potential.
Gabrielle Masson Aug 5, 2025 1:24pm
rocketship new blast off start up business development break off acquisition split

Velocity accelerates growth with buys in Poland and Germany

Jan 3, 2024 12:55pm
image of CSLs new RD facility

CSL Behring unveils its largest R&D site, slated to open in 2022

Sep 14, 2022 10:45am
deal

ResMed continues German expansion with Mementor buy

Aug 2, 2022 1:00pm
COVID-19 danger coronavirus pandemic quarantine

InflaRx to take failed COVID treatment to FDA anyway

Jul 26, 2022 11:20am
acquisition magnet

ResMed drops $1B on German software developer

Jun 14, 2022 10:50am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings